Janus Henderson Investors US’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
$21M Sell
2,166,766
-61,039
-3% -$591K 0.02% 605
2016
Q4
$23.2M Buy
2,227,805
+42,969
+2% +$447K 0.02% 589
2016
Q3
$27.1M Sell
2,184,836
-12,568
-0.6% -$156K 0.02% 543
2016
Q2
$25.6M Buy
2,197,404
+1,903,256
+647% +$22.2M 0.02% 534
2016
Q1
$3.25M Sell
294,148
-4,024,167
-93% -$44.4M ﹤0.01% 840
2015
Q4
$52.7M Sell
4,318,315
-23,200
-0.5% -$283K 0.04% 401
2015
Q3
$70.8M Buy
4,341,515
+755,481
+21% +$12.3M 0.06% 347
2015
Q2
$76M Buy
3,586,034
+603,182
+20% +$12.8M 0.06% 357
2015
Q1
$53.6M Buy
+2,982,852
New +$53.6M 0.04% 437